JamesAlbertConnellyMD

Pediatric Hematology & Oncology • Nashville, TN

Assistant Professor, Department of Pediatrics, Vanderbilt University Medical Center

Join to view full profile

Dr. Connelly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Connelly's full profile

Already have an account?

Office
2200 Childrens Way
Nashville, TN 37232
Phone+1 615-936-2000

Fax+1 615-936-0605

Education & Training

University of MichiganFellowship, Pediatric Hematology/Oncology, 2006 - 2009
University of MichiganResidency, Pediatrics, 2003 - 2006
Washington University in St. Louis School of MedicineClass of 2003

Certifications & Licensure

TN State Medical License 2016 - 2026
AL State Medical License 2020 - 2020
MI State Medical License 2003 - 2018
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Stem Cell Related Donor Safety Study Start of enrollment: 2010 Jan 01
Completed
Natural History Study of SCID Disorders Start of enrollment: 2010 Sep 02
Enrolling by invitation
Patients Treated for SCID (1968-Present) Start of enrollment: 2011 May 15
Enrolling by invitation
Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia Start of enrollment: 2013 Jun 01
Completed
Phase 1, Phase 2
Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease Start of enrollment: 2012 Mar 01
Completed
Phase 2
Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990 Start of enrollment: 2014 Feb 02
Completed
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995 Start of enrollment: 2014 Jun 01
Enrolling by invitation
Conditioning SCID Infants Diagnosed Early Start of enrollment: 2018 Oct 22
Recruiting
Phase 2
Roles: Principal Investigator, Contact
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) Start of enrollment: 2023 Jan 25
Recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

3 citations
An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease.
Adetola A Kassim, Josu de la Fuente, Erfan Nur, Karina L Wilkerson, Ali D Alahmari
Blood. 2024-06-20
1 citations
Applying a risk prediction model for bloodstream infection in a febrile, nonseverely neutropenic cohort of pediatric stem cell transplant patients.
Kasey Jackson, Victoria Anderson, Zhiguo Zhao, Carrie L Kitko, James A Connelly
Cancer. 2023-05-15
Irradiation-free, T-cell replete haploidentical transplant for Fanconi anaemia, weighing the benefits.
James A Connelly, Bipin N Savani
British Journal of Haematology. 2022-12-01

Journal Articles

Reduced Intensity Conditioning for Hematopoietic Cell Transplant for HLH and Primary Immune Deficiencies: BMT CTN 1204
Shalini Shenoy, K Scott Baker, Elizabeth O Stenger, Mary Eapen, Carl Allen, Lauri Burroughs, Philip Roehrs, Catherine M Bollard, Rabi Hanna, Jeffrey R Andolina, James ..., Blood

Abstracts/Posters

Quality of Life and Patient Reported Outcomes in Severe Chronic Neutropenia
James A. Connelly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019